|Articles|March 1, 2011
- Pharmaceutical Executive-03-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2011
Castellani Takes Charge at PhRMA
Advertisement
Articles in this issue
over 15 years ago
PICASSO—Truly a Work of Artover 15 years ago
The Netherlands: Innovation through Collaborationover 15 years ago
Restructured for Successover 15 years ago
The "Other" Innovationover 15 years ago
Where have all the Scientists Gone?over 15 years ago
Making Sense of Market Chaosover 15 years ago
Pharm Exec's Seventh Annual Media Auditover 15 years ago
New Tools Track Safety, Value in Medicineover 15 years ago
A Rule of Thumb Gets Shot Downover 15 years ago
John Castellani: Industry's Level Bet on a Dizzying FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5